The cost of a life-saving drug in Canada is rising by 3,000 per cent. A national pharmacare plan could bring order to this chaotic world of Canadian drug prices.
- Associate professor, Department of Family and Community Medicine, University of Toronto
- Professor Emeritus of Health Policy and Management, York University, Canada
- University of Sydney
Health Canada is proposing to allow some prescription drugs into the country with only ‘cursory clinical review.’ Here’s why we should be worried.
Health Canada proposes to increase fees to the pharmaceutical industry for prescription drug approval. This will compromise drug safety and is a risk to the health of the Canadian public.
Negotiators from 11 countries have been racing to resurrect the near-dead Trans-Pacific Partnership Agreement before the Asia-Pacific Economic Cooperation (APEC) summit this weekend.
Contact Joel for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Toronto, Canada
- Article Feed
- ORCID
-
- Joined



